Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/ALKS-5461> ?p ?o }
- ALKS-5461 wikiPageWikiLink Psychological_condition.
- ALKS-5461 wikiPageWikiLink Psychotomimetic.
- ALKS-5461 wikiPageWikiLink Rapastinel.
- ALKS-5461 wikiPageWikiLink Receptor_antagonist.
- ALKS-5461 wikiPageWikiLink Refractory_depression.
- ALKS-5461 wikiPageWikiLink Remission_(medicine).
- ALKS-5461 wikiPageWikiLink Samidorphan.
- ALKS-5461 wikiPageWikiLink Sedation.
- ALKS-5461 wikiPageWikiLink Selective_serotonin_reuptake_inhibitor.
- ALKS-5461 wikiPageWikiLink Serotonin-norepinephrine_reuptake_inhibitor.
- ALKS-5461 wikiPageWikiLink Serotonin–norepinephrine_reuptake_inhibitor.
- ALKS-5461 wikiPageWikiLink Stress_(biology).
- ALKS-5461 wikiPageWikiLink Sublingual.
- ALKS-5461 wikiPageWikiLink Sublingual_administration.
- ALKS-5461 wikiPageWikiLink Substance_dependence.
- ALKS-5461 wikiPageWikiLink Therapeutic_effect.
- ALKS-5461 wikiPageWikiLink Tolerability.
- ALKS-5461 wikiPageWikiLink Toxicity.
- ALKS-5461 wikiPageWikiLink Treatment-resistant_depression.
- ALKS-5461 wikiPageWikiLink United_States.
- ALKS-5461 wikiPageWikiLink Vilazodone.
- ALKS-5461 wikiPageWikiLink Vomiting.
- ALKS-5461 wikiPageWikiLink Xerostomia.
- ALKS-5461 wikiPageWikiLink Κ-opioid_receptor.
- ALKS-5461 wikiPageWikiLink Μ-opioid_receptor.
- ALKS-5461 wikiPageWikiLinkText "ALKS-5461".
- ALKS-5461 atcPrefix "none".
- ALKS-5461 caption "Buprenorphine + samidorphan".
- ALKS-5461 class Opioid_antagonist.
- ALKS-5461 class Opioid_modulator.
- ALKS-5461 component "Buprenorphine".
- ALKS-5461 component "Samidorphan".
- ALKS-5461 drugName "ALKS-5461".
- ALKS-5461 hasPhotoCollection ALKS-5461.
- ALKS-5461 routesOfAdministration "Sublingual".
- ALKS-5461 type "combo".
- ALKS-5461 width "250".
- ALKS-5461 wikiPageUsesTemplate Template:Antiaddictives.
- ALKS-5461 wikiPageUsesTemplate Template:Antidepressants.
- ALKS-5461 wikiPageUsesTemplate Template:Citation_needed.
- ALKS-5461 wikiPageUsesTemplate Template:Drugbox.
- ALKS-5461 wikiPageUsesTemplate Template:Opioidergics.
- ALKS-5461 wikiPageUsesTemplate Template:Reflist.
- ALKS-5461 subject Category:Antidepressants.
- ALKS-5461 subject Category:Combination_drugs.
- ALKS-5461 subject Category:Drug_rehabilitation.
- ALKS-5461 subject Category:Kappa_antagonists.
- ALKS-5461 subject Category:Morphinans.
- ALKS-5461 subject Category:Semisynthetic_opioids.
- ALKS-5461 subject Category:Synthetic_opioids.
- ALKS-5461 hypernym Formulation.
- ALKS-5461 type ChemicalSubstance.
- ALKS-5461 type Drug.
- ALKS-5461 type ChemicalObject.
- ALKS-5461 type Thing.
- ALKS-5461 type Q8386.
- ALKS-5461 comment "ALKS-5461 is a combination drug formulation of buprenorphine and samidorphan which is under development by Alkermes as an adjunct to antidepressant therapy in treatment-resistant depression (TRD). It is also under development by Alkermes as a treatment for cocaine dependence, which is being funded by a grant from the National Institute on Drug Abuse (NIDA).".
- ALKS-5461 label "ALKS-5461".
- ALKS-5461 sameAs m.0113h8jm.
- ALKS-5461 sameAs Q18204530.
- ALKS-5461 sameAs Q18204530.
- ALKS-5461 wasDerivedFrom ALKS-5461?oldid=679115406.
- ALKS-5461 depiction Buprenorphine_and_samidorphan.svg.
- ALKS-5461 isPrimaryTopicOf ALKS-5461.
- ALKS-5461 name "ALKS-5461".